GlassScriptPhysician profile
Teresa P Mann
NPI 1174632277
$4,887.55
in general payments reported to CMS, 2019-2025
20 companies · $750 in 2025
The $750 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $244 · 2021: $1,008 · 2022: $555 · 2023: $625 · 2024: $941 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,289 · Education: $27.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,288.67 |
| Education | $27.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,521.69 | 2019-2025 | |
| Allergan, INC. | $1,149.73 | 2019-2022 | |
| Merz North America, INC. | $380.94 | 2019-2023 | Xeomin |
| Leo Pharma INC. | $361.92 | 2022-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $289.43 | 2022-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $226.69 | 2019-2023 | |
| Lilly USA, LLC | $180.03 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $149.86 | 2019-2025 | |
| Pfizer INC. | $115.88 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $104.47 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $72.25 | 2021-2025 | |
| Incyte Corporation | $55.89 | 2024-2025 | Opzelura |
| Genentech USA, INC. | $54.80 | 2024-2025 | Xolair |
| Ucb, INC. | $52.95 | 2023-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $47.60 | 2023-2025 | Tremfya, Simponi, Simponi Aria |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $44.45 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.30 | 2023-2024 | Spevigo |
| Organon LLC | $16.85 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.40 | 2021 | |
| Dusa Pharmaceuticals, INC. | $14.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teresa Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.